NASDAQ · Medical - Diagnostics & Research

ISPC (ISPC) Stock

$2.03 +1.00% NASDAQ: ISPC Healthcare

Valuation

MetricValue
Price$2.03
Market Cap$281890
P/E Ratio-0.64
P/B Ratio14.07
P/S Ratio0.36
EPS (TTM)$-91.20
52-Week High$127.20
52-Week Low$1.97
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.28%
ROA-59.44%
ROCE-290.71%
Gross Margin1.25%
Operating Margin-4.65%
Net Margin-5.44%
Debt/Equity0.09
Current Ratio1.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$11.0M$10.0M$10.0M$9.0M$2.0M
Operating Profit$-6.0M$-10.0M$-11.0M$-13.0M$-9.0M
Net Profit$-9.0M$-10.0M$-11.0M$-12.0M$-10.0M
EPS$-980.40$-817.60$-982.00$-703.20$-91.20
Op Margin-53.2%-97.9%-112.5%-137.0%-465.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$36.0M$25.0M$16.0M$9.0M$10.0M
Total Liabilities$6.0M$4.0M$6.0M$6.0M$6.0M
Cash$28.0M$15.0M$2.0M$2.0M$7.0M
Borrowings$3.0M$0$0$0$0

Latest News

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement GlobeNewswire · May 12, 2026 iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement GlobeNewswire · May 9, 2026 iSpecimen Announces 1-for-40 Reverse Stock Split TMX Newsfile · Apr 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-6.0M$-6.0M$-8.0M$-4.0M
Investing Cash Flow$-2.0M$-6.0M$-12.0M$2.0M$-1.0M
Financing Cash Flow$-4.0M$0$0$4.0M$0
Net Cash Flow$27.0M$-12.0M$-13.0M$0$5.0M
Free Cash Flow$-12.0M$-9.0M$-11.0M$-8.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-3.98
EV / EBITDA0.32
FCF Yield-596.52%
Quick Ratio1.12
Interest Coverage—
Return 1Y-94.84%
Return 3Y-99.79%
Return 5Y-99.95%

Ownership

Insiders Held0.07%
Institutions Held1.50%
Institutions Float Held1.50%
Institutional HolderSharesReport Date
IFP Advisors, Inc8,2002026-06-30
Geode Capital Management, LLC7,8272026-03-31
UBS Group AG1,3442026-03-31
Jane Street Group, LLC1,3912026-03-31
Citadel Advisors Llc1,2622026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIAF $0.63 -2.64% -0.19 $2.84M 0.00%
BIVI $1.52 +6.29% -0.11 $11.46M 0.00%
BJDX $1.10 +6.80% -0.32 $498895 0.00%
GLMD $0.62 +3.67% -0.25 $5.13M 0.00%
HSCS $2.18 +4.81% -0.70 $4.71M 0.00%

About ISPC

ISPC is led by CEO Katharyn Field, employs 24 people, headquartered in US, publicly traded since 2021.

ISPC stock trades at $2.03 with a market capitalization of $281890. The stock is valued at a price-to-earnings (P/E) ratio of -0.64, price-to-book of 14.07, price-to-sales of 0.36. Over the past 52 weeks the stock has ranged between $1.97 and $127.20, and currently trades 98.4% below its 52-week high.

On profitability, ISPC generates a return on equity (ROE) of -3.28%, return on capital employed of -290.71%, an operating margin of -4.65%, a net profit margin of -5.44%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides